126 related articles for article (PubMed ID: 21241374)
1. Insulin-like growth factor-1 in psoriatic plaques treated with PUVA and methotrexate.
El-Komy M; Amin I; Zidan A; Kadry D; Zeid OA; Shaker O
J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1288-94. PubMed ID: 21241374
[TBL] [Abstract][Full Text] [Related]
2. Estimation of tissue osteopontin levels before and after different traditional therapeutic modalities in psoriatic patients.
El-Eishi NH; Kadry D; Hegazy RA; Rashed L
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):351-5. PubMed ID: 22221192
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator receptor (PPAR) β/δ in psoriatic patients before and after two conventional therapeutic modalities: methotrexate and PUVA.
El Eishi N; Hegazy R; Abou Zeid O; Shaker O
Eur J Dermatol; 2011; 21(5):691-5. PubMed ID: 21697059
[TBL] [Abstract][Full Text] [Related]
4. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
[TBL] [Abstract][Full Text] [Related]
5. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic effect of methotrexate and PUVA on psoriasis.
Shaker OG; Khairallah M; Rasheed HM; Abdel-Halim MR; Abuzeid OM; El Tawdi AM; El Hadidi HH; Ashmaui A
Cell Biochem Biophys; 2013 Nov; 67(2):735-42. PubMed ID: 23504632
[TBL] [Abstract][Full Text] [Related]
7. Increased insulin-like growth factor binding protein-3 expression level in psoriatic tissue before and after systemic treatment with cyclosporine A and methotrexate.
Ozden MG; Ilter N; Suer OE; Solaktekin N; Gürer MA
Int J Dermatol; 2008 Nov; 47(11):1177-83. PubMed ID: 18986456
[TBL] [Abstract][Full Text] [Related]
8. Connexin 26 in psoriatic skin before and after two conventional therapeutic modalities: methotrexate and PUVA.
Shaker O; Abdel-Halim M
Eur J Dermatol; 2012; 22(2):218-24. PubMed ID: 22361809
[TBL] [Abstract][Full Text] [Related]
9. Systemic photochemotherapy decreases the expression of IFN-γ, IL-12p40 and IL-23p19 in psoriatic plaques.
Ravić-Nikolić A; Radosavljević G; Jovanović I; Zdravković N; Mitrović S; Pavlović S; Arsenijević N
Eur J Dermatol; 2011; 21(1):53-7. PubMed ID: 21227895
[TBL] [Abstract][Full Text] [Related]
10. [Photochemotherapy for psoriatic patients treated with corticosteroids and methotrexate].
Gschnait F; Konrad K; Hönigsmann H; Wolff K
Hautarzt; 1977 Dec; 28(12):632-7. PubMed ID: 599023
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
Markham T; Mathews C; Rogers S; Mullan R; Bresnihan B; Fitzgerald O; Veale DJ; Fearon U
Br J Dermatol; 2006 Dec; 155(6):1191-6. PubMed ID: 17107388
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
[TBL] [Abstract][Full Text] [Related]
13. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
14. [Cost-effectiveness analysis comparing methotrexate with PUVA therapy for moderate-severe psoriasis in the sanitary area of Badajoz].
de Argila D; Rodríguez-Nevado I; Chaves A
Actas Dermosifiliogr; 2007; 98(1):35-41. PubMed ID: 17374331
[TBL] [Abstract][Full Text] [Related]
15. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis.
Yang J; Li Y; Liu YQ; Long JW; Tian F; Dong J; Shen GX; Tu YT; Tao J
Eur J Dermatol; 2009; 19(1):29-33. PubMed ID: 19059832
[TBL] [Abstract][Full Text] [Related]
16. Effects of PUVA on the epidermal melanocyte population in psoriatic patients.
Rosdahl IK; Swanbeck G
Acta Derm Venereol; 1980; 60(1):21-6. PubMed ID: 6153829
[TBL] [Abstract][Full Text] [Related]
17. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment.
Yazici AC; Tursen U; Apa DD; Ikizoglu G; Api H; Baz K; Tasdelen B
Arch Dermatol Res; 2005 Dec; 297(6):249-55. PubMed ID: 16215763
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
Mashkilleysson AL; Mashkilleysson NA
Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
[TBL] [Abstract][Full Text] [Related]
19. Changes of skin blood flow and color on lesional and control sites during PUVA therapy for psoriasis.
Suh DH; Kwon TE; Kim SD; Park SB; Kwon OS; Eun HC; Youn JI
J Am Acad Dermatol; 2001 Jun; 44(6):987-94. PubMed ID: 11369911
[TBL] [Abstract][Full Text] [Related]
20. Expression of insulin-like growth factor-I in lesional and non-lesional skin of patients with morphoea.
Fawzi MM; Tawfik SO; Eissa AM; El-Komy MH; Abdel-Halim MR; Shaker OG
Br J Dermatol; 2008 Jul; 159(1):86-90. PubMed ID: 18489607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
